miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer death with poor prognosis.
• MicroRNAs (miRNAs) are crucial regulators of gene expression involved in cancer development.
• Dysregulation of specific miRNAs, like miR-199a-3p/5p, is implicated in various diseases, including cancer.

Purpose of the Study:

• To investigate the role of miR-199a-3p/5p in non-small cell lung cancer (NSCLC).
• To identify the molecular targets and pathways regulated by miR-199a-3p/5p in NSCLC.
• To explore the therapeutic potential of miR-199a-3p/5p in NSCLC treatment.

Main Methods:

• Analysis of miR-199a-3p/5p expression in NSCLC tissues, cell lines, and patient databases.
• Functional assays to assess the impact of miR-199a-3p/5p overexpression on NSCLC cell proliferation, migration, and apoptosis.
• Bioinformatic prediction and experimental validation of miR-199a-3p/5p targets, focusing on the Rheb/mTOR signaling pathway.
• In vivo studies to evaluate the anti-tumor and anti-metastasis effects of miR-199a.
• Assessment of miR-199a-3p/5p in enhancing gefitinib sensitivity in EGFR-T790M mutated NSCLC.

Main Results:

• miR-199a-3p/5p were significantly downregulated in NSCLC.
• Overexpression of miR-199a-3p/5p suppressed NSCLC cell proliferation and migration while promoting apoptosis.
• Rheb was identified as a direct target of miR-199a-3p/5p, mediating the inhibition of the mTOR signaling pathway.
• miR-199a demonstrated significant inhibition of tumor growth and metastasis in vivo.
• miR-199a-3p/5p enhanced gefitinib sensitivity in EGFR-T790M NSCLC.

Conclusions:

• miR-199a-3p/5p function as tumor suppressors in NSCLC by targeting Rheb and inhibiting the mTOR pathway.
• The miR-199a/Rheb/mTOR axis plays a critical role in NSCLC progression.
• miR-199a-3p and miR-199a-5p hold potential as early diagnostic markers and therapeutic targets for NSCLC.